Vertiva: Advancing Automated Drug Delivery For Next-Generation Therapies

The Vertiva platform is a cutting-edge solution designed to revolutionize automated drug delivery systems for pharmaceutical and biotech applications. This next-generation device combines precision, flexibility, and user-centric design, making it ideal for both subcutaneous and intramuscular drug administration.

In this video, discover how Vertiva supports combination products, enhancing drug delivery efficiency while ensuring patient comfort. The platform is engineered for adaptability, accommodating various drug formulations and viscosities. Its automated, customizable features make it suitable for both self-administration and clinical use, providing pharmaceutical companies with a scalable, high-performance solution.

Key benefits of the Vertiva platform include:

• Advanced automation for precise and controlled drug delivery
• Enhanced patient experience with ergonomic, user-friendly design
• Flexibility to accommodate multiple drug formulations
• Regulatory compliance and seamless integration with existing manufacturing processes

By leveraging Stevanato Group’s expertise in device development and primary packaging, Vertiva represents a significant advancement in drug delivery technology. It not only enhances efficiency in drug administration but also improves safety, patient adherence, and treatment outcomes.

Watch the video to see how Vertiva is setting a new standard for combination product drug delivery, helping pharmaceutical companies bring innovative therapies to market faster and more efficiently.